Biotivity A-C Membrane Socket Preservation Study

Part of paid clinical trials in Baltimore, Maryland.

Sponsor
University of Maryland, Baltimore
Study ID
NCT07091448
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Alveolar Ridge Preservation

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Interventions

  • Amnion chorion membrane — DEVICE
    Alveolar ridge preservation of a single extraction socket site with a barrier membrane Biotivity™ A/C Plus.
  • Collagen membrane — DEVICE
    Alveolar ridge preservation of a single extraction socket site with a barrier membrane CopiOs..

Study Details

This is a prospective, randomized controlled pilot clinical trial evaluating the efficacy of a human placental-derived amnion chorion membrane (Biotivity™ A/C Plus Membrane) versus a conventional collagen membrane in alveolar ridge preservation (ARP) following atraumatic extraction of single posterior teeth. A total of 12 subjects will be enrolled at the University of Maryland School of Dentistry. The study aims to assess both soft tissue wound healing and hard/soft tissue dimensional changes over a 5-month period prior to dental implant placement. Throughout the approximately 6-month study duration, participants will undergo oral exams, x-rays, surgical procedures, and follow-up visits. All participants will undergo routine tooth extraction, bone graft material and barrier placement, and dental implant placement. Participation in the study is voluntary, and the alternative is to continue routine dental care. Risks include minor discomfort from procedures such as tooth extraction and implant placement. The major benefit of participation in the study is the preservation of jaw dimensions following extraction, which will simplify the placement of a dental implant.

Key Dates

Start date
Apr 1, 2026
Status verified
Jan 2026
Primary completion
Oct 31, 2027
Completion
Oct 31, 2028

Study Design

Enrollment
12 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Alveolar ridge preservation with amnion chorion membrane
    The patients in both groups will go through the same treatment but with two different barrier membrane depending on the assigned group. The patients in this group will have alveolar ridge preservation with the amnion chorion membrane called Biotivity™ A-C Plus.
  • Active Comparator: Alveolar ridge preservation with collagen membrane
    The patients in both groups will go through the same treatment but with two different barrier membrane depending on the assigned group. The patients in this group will have alveolar ridge preservation with the amnion chorion membrane called CopiOs.

Primary Outcome Measure

Soft Tissue Wound Healing Score Using Wound Healing Indices [ Time Frame: Over the course of the study (From the time of study enrollment Alveolar Ridge Preservation [Visit 2] to 5-month dental implant placement [Visit6]. ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Maryland School of DentistryBaltimoreMaryland21201
Hanae Saito, DDS MS CCRC
410-706-3646
Hanae Saito, DDS MS CCRC (PRINCIPAL_INVESTIGATOR)

Find similar trials in Baltimore, MD

Related Studies